Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.
作者信息
Brownlee Thomas, Olson Colleen, Deschamps Michelle
机构信息
, BSP, was, at the time this report was prepared, a candidate in the Bachelor of Science in Pharmacy program, University of Saskatchewan, and a pharmacy summer student with the Saskatchewan Cancer Agency, Saskatoon, Saskatchewan. He is now completing a pharmacy practice residency with Alberta Health Services - Calgary Zone.
, BA, BSP, is with the Saskatchewan Cancer Agency, Saskatoon, Saskatchewan.
出版信息
Can J Hosp Pharm. 2018 Jul-Aug;71(4):276-281. Epub 2018 Aug 28.
Abstract
摘要
相似文献
1
Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.转移性前列腺癌患者中恩杂鲁胺与补充替代药物之间的药物相互作用识别：一例报告
Can J Hosp Pharm. 2018 Jul-Aug;71(4):276-281. Epub 2018 Aug 28.
2
Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer.系统评价和网络荟萃分析：针对无症状/轻度症状转移性去势抵抗性前列腺癌化疗初治患者的治疗方法。
Value Health. 2018 Oct;21(10):1259-1268. doi: 10.1016/j.jval.2018.03.012. Epub 2018 May 4.
4
Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.卡巴他赛用于先前接受含多西他赛方案治疗的激素难治性转移性前列腺癌：英国国家卫生与临床优化研究所单一技术评估的证据审查小组观点
Pharmacoeconomics. 2017 Apr;35(4):415-424. doi: 10.1007/s40273-016-0457-1.
本文引用的文献
1
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.药物相互作用在前列腺癌治疗中的作用：以阿比特龙/泼尼松和恩杂鲁胺为例。
Cancer Treat Rev. 2017 Apr;55:71-82. doi: 10.1016/j.ctrv.2017.03.001. Epub 2017 Mar 9.
2
Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy.游离睾酮水平在接受二线治疗的转移性去势抵抗性前列腺癌患者中的作用。
Oncol Lett. 2017 Jan;13(1):22-28. doi: 10.3892/ol.2016.5392. Epub 2016 Nov 17.
3
Drug-drug interactions in older patients with cancer: a report from the 15th Conference of the International Society of Geriatric Oncology, Prague, Czech Republic, November 2015.老年癌症患者的药物相互作用：来自国际老年肿瘤学会第15届会议的报告，2015年11月于捷克共和国布拉格
Ecancermedicalscience. 2016 Jan 14;10:611. doi: 10.3332/ecancer.2016.611. eCollection 2016.
4
Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.恩杂鲁胺对比比卡鲁胺用于去势抵抗性前列腺癌：STRIVE 试验。
J Clin Oncol. 2016 Jun 20;34(18):2098-106. doi: 10.1200/JCO.2015.64.9285. Epub 2016 Jan 25.
5
Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study.恩扎卢胺对比比卡鲁胺用于转移性前列腺癌患者的疗效和安全性（TERRAIN）：一项随机、双盲、2 期研究。
Lancet Oncol. 2016 Feb;17(2):153-163. doi: 10.1016/S1470-2045(15)00518-5. Epub 2016 Jan 14.
6
Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm.服用草药的癌症患者：临床目的、相关因素及对益处或危害的认知综述
J Ethnopharmacol. 2015 Dec 4;175:58-66. doi: 10.1016/j.jep.2015.08.052. Epub 2015 Sep 3.
7
Pharmacokinetic Drug Interaction Studies with Enzalutamide.恩杂鲁胺的药代动力学药物相互作用研究
Clin Pharmacokinet. 2015 Oct;54(10):1057-69. doi: 10.1007/s40262-015-0283-1.
8
Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine.癌症患者对其疾病的认知、自我效能感、控制点以及补充和替代医学的使用情况。
J Cancer Res Clin Oncol. 2015 Aug;141(8):1449-55. doi: 10.1007/s00432-015-1940-3. Epub 2015 Feb 22.
9
Herb-drug interactions in oncology.肿瘤学中的草药-药物相互作用。
Clin Pharmacol Ther. 2014 Apr;95(4):354-5. doi: 10.1038/clpt.2014.18.
10
Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review.癌症患者对补充替代医学的披露和医患沟通：系统评价。
Oncologist. 2012;17(11):1475-81. doi: 10.1634/theoncologist.2012-0223. Epub 2012 Aug 29.
Zotero 插件